New wound care product used to reduce inflammation

Share this content:
New wound care product used to reduce inflammation
New wound care product used to reduce inflammation

BIOVANCE, an amniotic membrane allograft derived from a human placenta, is now available for those looking for a wound care product.

Made by Alliqua Biomedical Inc., BIOVANCE is meant to reduce inflammation, support tissue growth and minimize pain. Uses include as a treatment for acute or chronic wounds as well as venous leg ulcers. On Monday, the company announced it had received product reimbursement Q code Q4154 through the Level II Healthcare Common Procedure Coding System.